Advinus will combine its services with AgilityBio’s imaging services that use BioImagene’s digital pathology solutions for cancer diagnosis and research.
This partnership will bring about a synergy between drug development at US-based biotech and pharma industries and India’s life sciences service industry, the two companies said.
Nimish Vachharajani, vice president and head of pharmaceutical development at Advinus, said: “This alliance brings together the preclinical development services of Advinus and the technology of AgilityBio together for our customers. In particular for our international clients, digitalization of slides from toxicology studies will offer an affordable alternative to reduce travel time and costs for peer-reviews.”